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Abstract
Cellular Angiofibroma (CA) represents a quite recently described mesenchymal tumour that occurs in both genders,
in particular in the vulvo-vaginal region in women and in the inguino-scrotal area in men. The first description of
this tumour dates from Nucci et al. article in 1997; since then, the literature reports different reviews and case report of
this tumour in both genders, but no article specifically addressing CA treatment and follow-up in women. In this
review we collected all 79 published female CA cases, analyzing the clinical, pathological and immunohistochemical
features of the tumour.
CA affects women mostly during the fifth decade of life, it is generally a small and asymptomatic mass that mainly
arises in the vulvo-vaginal region, although there are reported pelvic and extra-pelvic cases. The treatment requires a
simple local excision due to an extremely low ability to recurrent locally and no chance to metastasize. Throughout the
immunohistochemical and pathological findings it is also easily possible a differential diagnosis from the other soft
tissue tumours which affect the vulvo-vaginal area, such as spindle cell lipoma, solitary fibrous tumour,
angiomyofibroblastoma and aggressive angiomyxoma.
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Introduction
Cellular angiofibroma (CA) belongs to soft tissue tu-
mours that predominantly occur in the distal genital
tract of both genders: vulvo-vaginal region in women
and inguino-scrotal area in men [1, 2], although extrage-
nital localizations have also been described [3–5].
The first soft tissue tumour with a relatively pelvic
site-specificity was a benign stromal polyp described in
the early 1960 [6].
Among the mesenchymal tumours involving the vulva,
we can distinguish the lesions that can arise at any site,
including the vulva, and those more characteristics of
this area. The former group includes leiomyoma (Fig. 1),
lipoma (Fig. 2) and solitary fibrous tumour (Fig. 3) while
the second group includes CA (Fig. 4) along with aggres-
sive angiomyxoma (Fig. 5), angiomyofibroblastoma (Fig. 6)
and fibroepithelial stromal polyp [7].
Cellular angiofibroma is a rare benign mesenchymal
lesion, first described by Nucci et al. in 1997 [1] in a
series of 6 cases that occurred almost exclusively in the
vulva of middle-aged women. A short time later, Laskin
et al. [2] described 11 cases of a histologically similar le-
sion named “angiomyofibroblastoma-like” tumour, which
affects the adult men in the inguino-scrotal area. The
World Health Organization classification [8] established
that the term “Cellular angiofibroma” includes this kind
of lesion in both females and males, because there are
no reproducible morphologic differences between the
two genders. Macroscopically these lesions are com-
monly well circumscribed, localized in the superficial
soft tissue and are characterized by 2 main components:
bland spindle cells and small to medium-sized vessels
with mural hyalinization [9].
Since the first description by Nucci, only few studies
have been published in the literature, most of which
consisted of single case-reports or reviews which include
cases from both genders.* Correspondence: susanna.santagni@asmn.re.it
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Here, we reviewed all the cases of CA arising in
women since 1997, to clarify the outcome and to identify
the best treatment.
Review
Materials and methods
We collected and analyzed the published articles in the
literature regarding CA from January 1997 to December
2014, using Pubmed research and the terminologies “cellular
angiofibroma”, “vulvovaginal mesenchymal tumour”,
“vulvovaginal benign tumour”, “vulvovaginal stromal
tumour” and “vulvovaginal soft tissue tumour”. We selected
only the cases involving the female gender: a total of 79
published cases of CA were found. Where possible, we
contacted the authors to update the follow-up data, in
particular regarding local recurrences and/or metastases.
In the Tables 1 and 2 are reported the main clinical
features of the 74 vulvo-vaginal and pelvic CA and the
clinical finding of the 6 extra-pelvic CA, respectively.
Results
Clinical features
The 79 affected women have an age at presentation ran-
ging from 20 to 77 years (mean 46.1 years). The most
common anatomic site is the vulvo-vaginal region, in
particular labium majus area and vulva overall (18 and
35 cases, respectively). Outside the vulvo-vaginal region,
5 pelvic localizations are reported, including 4 perineum
and an urethral site. Six extra-pelvic CA are reported,
such as a left hip, lateral knee, chest wall, left axilla and
breasts [10], left hypocondrium [3, 5] and more recently,
we have reported the first case of retroperitoneal CA
arising in right paravesical space of a post-menopausal
woman [11].
The tumour size ranges from 0.6 to 12.3 cm, with a
mean size of 3.6 cm. A clinical diagnosis before surgery
is reported only in 25 cases. Among these, the most
common clinical presentation resembles a Bartholin’s
cyst (12/25, 48 % of cases), a not-specific solid mass
(7/25, 28 % of cases), vulval cyst (3/25, 12 % of cases),
Fig. 1 Leiomyoma at hematoxylin-eosin, 200X
Fig. 2 Lipoma at hematoxylin-eosin, 200X
Fig. 3 Solitary fibrous at hematoxylin-eosin, 200X
Fig. 4 Cellular angiofibroma at hematoxylin-eosin, 200X
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leyomioma (2/12, 8 % of cases) and lipoma (1/25, 4 % of
cases). In 8 cases of CA the time occurred between the
tumour’s occurrence and the surgical treatment is re-
ported: the mean is 16.6 month, ranging from 2 to
36 months.
CA is usually treated by simple excision; the involve-
ment or not of the surgical margins is reported in 47/78
(60.2 %) CA with 18 positive surgical margins (18/47,
38.2 %) and 29 negative surgical margins (29/47, 61.7 %);
only 5 cases (5/18, 27.8 %) of re-excision because in-
volved the surgical margin are reported.
Follow-up data are reported in 48/79 (60.7 %) cases
with a range of 3–240 months (mean 46.6 months): the
available follow-up data show that CA tends to not de-
velop local recurrences or metastasis also in case of
atypia or sarcomatous transformation. In 7 of the 12 pa-
tients with atypia or sarcomatous transformation follow
up data were available, no recurrence or metastases were
reported after a median follow-up of 14 months [9].
One patients died of metastatic carcinoma of unknown
primary origin, after 27 months from the diagnosis of
CA with sarcomatous component. In an another one,
the women died of breast cancer, 59 months after the
CA diagnosis, without CA recurrence or metastases
found meanwhile.
Only a local recurrence of vulvar CA is described after
6 months follow-up [12]. CA has been initially excised
with a rim of free-tumour tissue [12].
Pathological features
A macroscopic/microscopic description was reported in
63/79 (79.7 %) CA. Grossly, the neoplasm is described as
white or yellowish nodules, mostly firm and partly gelat-
inous of cystic in appearance, with a cut surface white
tan to grayish in color. Macroscopically, three cases is
recorded as polypoid lesions [13] and in other few cases
is appreciated a multilobulated appearance. CA is usu-
ally well-circumscribed, although focal extension into
surrounding soft tissue can be seen. Most lesions were
found in superficial soft tissue while 5 cases, all in the
vulvovaginal region, involve dermis [3]. There is reported
only one case with foci of haemorrhage [3] and none
showing foci of necrosis.
Microscopically, the CA is a cellular neoplasm, com-
posed of bland spindle shaped cells, proliferating in an
edematous to fibrous stroma, containing wispy collagen
bundles, numerous small to medium-sized thick-walled,
often hyalinized, vessels and a minor component of
adipose tissue [7]. The spindle cell component in most
cases is quite cellular and randomly distributed through-
out the lesion, focally forming short fascicles but gener-
ally without any particular pattern [3]. The spindle cells
usually have short, fusiform, ovoid, sometimes tapering
or polygonal nuclei with incospicuous nucleoli, while
their cytoplasm is palely eosinophilic with indistinct, ill-
defined borders or bipolar dendritic processes. Nuclear
grooves and intranuclear inclusions are commonly ob-
served [13]. A moderate number of inflammatory cells,
comprising lymphocytes and rarely neutrophils, are scat-
tered throughout the stroma [3]; the mast cells are often
abundant while multinucleated giant cells or epithelioid
cells are absent in this neoplasm.
Mitotic activity is very variable: indeed, a prominent
mitotic activity may be occasionally observed, and ab-
normal mitoses and cellular atypia are rarely present.
CA with atypia or sarcomatous trasformation was re-
ported in 12 women [9], no necrosis or hemorrhage was
observed in any case and the atypical or sarcomatous
component wasn’t morphologically recognizable on mac-
roscopically examination. Microscopically, the atypical
changes ranged from severely atypical cells dissemi-
nated within a background of usual CA to the forma-
tion of a discrete atypical foci. Similarly, the sarcomatous
Fig. 5 Aggressive angiomyxoma at hematoxylin-eosin, 200X
Fig. 6 Angiomyofibroblastoma at hematoxylin-eosin, 200X
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Table 1 Clinical features of 74 cases of Cellular Angiofibroma in vulvo-vaginal and pelvic regions
Case Age Author Site Size (media, cm) Treatment Follow-up (Months) Recurrence
1 50 Nucci Vulva 1,2 Simple excision UK UK
2 46 Nucci Lab maj 2 Local excision + 2 reexcisions 19 NER
3 39 Nucci Lab 2,15 Simple excision 12 NER
4 49 Nucci Lab 1,2 Simple excision UK UK
5 43 Nucci Vulva 2,3 UK UK UK
6 41 Nucci perineum 3 UK UK UK
7 37 Colombat Lab 2,5 UK UK UK
8 37 Curry Clitoral Hood 3,5 UK 15 UK
9 53 Dufau Lab maj 3,3 UK UK UK
10 46 Dargent Lab maj 2,33 Simple excision 149 NER
11 49 Dargent Clitoris 2,66 Simple excision 161 NER
12 49 Iwasa Lab maj 2 Simple excision 5 UK
13 39 Iwasa Vulva / UK UK UK
14 46 Iwasa Lab maj 2 Simple excision 168 NER
15 50 Iwasa Vulva 1,5 Simple excision UK UK
16 42 Iwasa Vulva 3 Simple excision 75 NER
17 42 Iwasa Perineum / UK UK UK
18 75 Iwasa Vulva 2,8 Simple excision 59 Died for Breast cancer
19 27 Iwasa Lab maj 1,1 Local excision + reexcision 50 NER
20 41 Iwasa Vulva 2,7 Simple excision 54 NER
21 68 Iwasa Vulva / Simple excision 17 NER
22 59 Iwasa Lab maj 2 Simple excision 41 NER
23 49 Iwasa Vulva / UK UK UK
24 37 Iwasa Hymen 4,8 Local excision with positive margins 24 NER
25 38 Iwasa vagina / UK UK UK
26 46 Iwasa Vulva 2,9 Simple excision 35 NER
27 47 Iwasa Lab maj 1,4 Simple excision 44 NER
28 22 Iwasa Inguinal region 12 Local excision + reexcision 18 NER
29 52 Iwasa Urethra / UK UK UK
30 47 Iwasa Vulva / UK UK UK
31 48 Iwasa Lab maj 3 Simple excision 8 NER
32 24 Iwasa Vagina 11 UK 6 NER
33 31 Iwasa Perineum 4 Simple excision UK UK
34 58 Iwasa Vagina 0,6 Simple excision UK UK
35 50 Iwasa Vulva 1,8 Simple excision 6 NER
36 58 Iwasa Vulva 3 Simple excision 9 NER
37 50 Iwasa Vulva / UK UK UK
38 49 McCluccage Lab maj 4 Simple excision 6 Local recurrence
39 20 McCluccage Not specified 2,4 Simple excision 240 NER
40 65 McCluccage Lab maj 5 Simple excision 12 NER
41 59 McCluccage Vulva 2 Simple excision 18 NER
42 58 Chen Vulva 2,7 Piecemeal excision 75 NER
43 52 Chen Vulva 3 Simple excision 27 NER, died for
cancer of UK origin
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component showed variable features, including an atypical
lipomatous tumour-like component, pleomorphic liposar-
coma and pleomorphic sarcoma [9].
Immunohistochemical features
In the Table 3 are summarized the available data about
the immunohistochemical findings of the selected arti-
cles. Immunohistochemical findings were reported only
in 44/79 (55.7 %) published CA because many articles
don’t distinguish the immunohistochemical features
between the male and female tumours.
Tumour cells are consistently negative for S-100protein
(40/40 cases, 100 %), while they show positivity for CD34
in 45.4 % (20/44) of the cases. The CD34 positivity,
together with typical muscle-markers positivity, as α-SMA
and desmin, in an extremely minority of tumours (α-SMA
positivity in 6 cases on 40 tested, 15 % and desmine posi-
tivity in 2/39 examined cases, 5.1 %), suggest a probable
fibroblastic rather than myofibroblastic differentiation.
When examined, the tumour cells also show an immuno-
reactivity for Vimentin. Another interesting finding is the
expression of Estrogen receptor and/or Progesterone re-
ceptors by neoplastic cells [5, 14–16], which can suggests
the role of an hormonal disturbance in the pathogenetic
mechanisms of this tumour. When evaluated, all cases of
CA show h-Caldesmon negativity (5/5 cases, 100 %) and
Keratin negativity (6/6 cases, 100 %).
Multifocal or diffuse p16 expression is present in the
atypical or sarcomatous areas of the CA, whilst is scattered
or absent in usual CA [9]. In Table 4 are summarized the
Table 1 Clinical features of 74 cases of Cellular Angiofibroma in vulvo-vaginal and pelvic regions (Continued)
44 34 Chen Vulva 1,2 Simple excision UK UK
45 32 Chen Vulva 4,85 Simple excision UK UK
46 25 Chen Vulva 1,3 Simple excision 42 NER
47 43 Chen Vulva 2,5 Simple excision 2 NER
48 59 Chen Vulva 1,3 Simple excision 14 NER
49 46 Chen Vulva 6,5 Simple excision 4 NER
50 71 Chen Vulva 7,5 Simple excision UK UK
51 39 Chen Vulva / Simple excision 7 NER
52 46 Chen Vulva 2 Simple excision UK UK
53 41 Flucke Perineum 3 Simple excision UK UK
54 39 Flucke Vagina 1 Local excision with positive margins 75 NER
55 50 Flucke Vulva 3 Local excision + reexcision 55 NER
56 51 Flucke Lab maj 2,7 Marginal excision 66 NER
57 44 Flucke Lab maj 2,3 Simple excision UK UK
58 50 Flucke Vulva 4 Local excision with positive margins UK UK
59 48 Flucke Vulva 8,5 Simple excision UK UK
60 42 Flucke Vulva 2,2 Simple excision UK UK
61 63 Flucke Clitoris 2,5 Local excision with positive margins 38 NER
62 27 Flucke Lab maj 8 Marginal excision UK UK
63 42 Flucke Vulva 1,7 Simple excision 30 UK
64 46 Flucke Lab maj 3 Marginal excision UK UK
65 55 Flucke Vulva 2,3 Simple excision 12 NER
66 57 Flucke Vulva 4,5 Simple excision 6 NER
67 47 Flucke Vulva 1,5 Local excision with positive margins UK UK
68 39 Flucke Vagina 9 Marginal excision UK UK
69 51 Rua Micheletti Lab maj 4,6 Simple excision 112 NER
70 31 Kerkuta Lab maj 4 Simple excision 10 NER
71 77 Lane Lab 4 Simple excision 12 NER
72 26 Arsenovic Vulva 8,5 Simple excision 90 NER
73 55 Maggiani Vagina 12,3 UK UK UK
74 20 Ahmadnia Both lab maj / Simple excision 12 NER
NER not evidence of recurrence, UK unknown
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immunohistochemical findings in the other soft tissue tu-
mors compared with CA [17, 18].
Discussion
Cellular angiofibroma is a quite recently described rare,
benign stromal tumour that occurs equally among men
and women: in female patients, CA most frequently
arises in the vulvo-vaginal region, although there are de-
scribed a lot of pelvic and extra-pelvic cases. Women are
affected most often in the fifth decade (mean age
46.1 years), earlier than men, affected in the seventh
decade. CA is characterized by its small size (mean value
3.6 cm) and usually well-circumscribed margins; it tends
to be an asymptomatic and slowly enlarging mass, so
CA tends to gradually increase in size after approxi-
mately 1–2 asymptomatic years, inducing women to
check with their doctor long time after the tumour
onset. CA is usually misdiagnosed with a Bartholin’s cyst
(12/25, 48 % of cases), a not-specific solid mass (7/25,
28 % of cases), vulval cyst (3/25, 12 % of cases), leyo-
mioma (2/12, 8 % of cases) and lipoma (1/25, 4 % of
cases). Six extra-pelvic CA are reported in literature.
Exceptionally, a young woman presented both vulvar
and extra-pelvic CA, particularly two vulvar CA on the
right and the left labia majora and three extravulvar CA
on the left axilla and both breasts were reported [10].
Nevertheless exist exceptional early symptomatic forms,
as well as our described case-report [11] in which the
woman complained coxalgia due to tumour’s position, in
retroperitoneal site, very near to obturator nerve.
There are many mesenchymal tumour which enter
into the differential diagnosis with CA as spindle cell lip-
oma, solitary fibrous tumour, mammary-type myofibro-
blastoma, angiomyfibroblastoma, aggressive angiomyxoma
and smooth muscle tumour (Table 4). Exceptionally, CA
has been diagnosed with these mesenchymal tumours,
such as with lipoma [19].
Spindle cell lipoma was first described by Enzinger
and Harvey [20] in 1975 as a benign lipomatous tumour
with a predilection for shoulder, back and posterior neck
region of middle-aged to elderly men. Occasional cases
may occur in a wide variety of sites, including one
reported case arising in the vulva [21]. The tumour
consists of mature adipocytes, bland spindle cells and
short bundles of brightly eosinophilic ropy collagen [7].
In fact, CA and spindle cell lipoma have similar histo-
logical features, but can be distinguished by the rarity of
spindle cell lipoma in vulvovaginal region and the pres-
ence, in CA, of more numerous vessels with thickened,
hyalinized walls, compared with capillary-sized thin-
walled vessels in spindle cell lipoma. The immunostain-
ing is not helpful because the spindle cells of both
tumours are CD34 positive, in particular CD34 is posi-
tive in about 60 % of CA and in 100 % of spindle cell
lipoma [8].
Solitary fibrous tumour has been reported in a wide var-
iety of locations, including vulva and perineum [22, 23].
This tumour shows a patternless spindle cell proliferation
of alternating hypercellular and hypocellular areas, associ-
ated with dense collagen bundles, stromal keloidal-type
hyalinization and hemangiopericytoma-like vessels [8].
Both solitary fibrous tumour and CA may contain fat in
the lesion [24] and show often positivity for CD34 [8], but
CA differs due to more evenly distributed cellularity,
bland spindle cells with short bundles of collagen and
more rounded small- to medium-sized vessels.
Mammary-type myofibroblastoma, as we know for its
typical breast localization, has been described also at
extramammary locations, especially in the inguinal re-
gion, with a male predominance [25]. Grossly, this lesion
appears as a well circumscribed, nodular mass and,
microscopically, it is composed of spindle cells and adi-
pose tissue, separated by coarse bundles of hyalinized
collagen. In comparison of CA, the vessels in mammary-
type myofibroblastoma are incospicuous and the spindle
cells have a more fascicular arrangement. The tumour
cells consistently exhibit coexpression of desmin and
CD34 [25].
All these described tumours share similar morphologic
features and are characterized by bland ovoid to spindle-
shaped cells with wispy collagen, variably sized thick-
walled blood vessels and immunoreactivity to CD34.
In consideration of the clinical features, aggressive
angiomyxoma (AA) and angiomyofibroblastoma (AMF)
should also be included in the differential diagnosis of
CA. The former is a typical locally recurring tumour of
Table 2 Clinical features of 6 cases of extra-pelvic Cellular Angiofibroma
Case Age Author Site Size (media, cm) Treatment Follow-up (Months) Recurrence
75 52 Chen Left hip 3,5 Local excision + reexcision UK UK
76 63 Flucke Knee lateral 4 Simple excision 45 NER
77 43 Val-Bernal Chest wall 7 Simple excision 203 NER
78 38 Val-Bernal Left hypocondrium 3,5 Simple excision 104 NER
79 60 Mandato Retroperitoneim pelvicc 3,9 Simple excision 6 NER
80 20 Ahmadnia Left axilla + both breast / Simple excision 12 NER
NER not evidence of recurrence, UK unknown
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Table 3 Immunohistochemical features of cellular angiofibroma in women reported in literature
Case Author Vimentin CD34 S-100 α-SMA Desmin Keratin EMA ER PR h-Caldesmon CD10 CD99 CD31 CD117
1 Nucci + - - - - - -
2 Nucci + - - - - - -
3 Nucci + - - - - - -
4 Nucci + - - - - - -
5 Nucci +
6 Nucci +
10 Dargent + + - + - - + + - + - -
11 Dargent + - - + + - + - -
12 Iwasa + - + + + +
13 Iwasa + - + + + +
14 Iwasa + - + - + +
15 Iwasa + - + - + +
16 Iwasa + - - - + +
17 Iwasa + - - - - +
18 Iwasa + - - - - +
19 Iwasa + - - - - +
20 Iwasa + - - - - +
21 Iwasa + - - - - -
22 Iwasa + - - -
23 Iwasa - - - -
24 Iwasa - - - -
25 Iwasa - - - -
26 Iwasa - - - -
27 Iwasa - - - -
28 Iwasa - - - -
29 Iwasa - - - -
30 Iwasa - - - -
31 Iwasa - - - -
32 Iwasa - - - -
33 Iwasa - - - -
34 Iwasa - - - -
35 Iwasa - - - -
38 McCluccage + - - - - + + + - -
39 McCluccage + + - - - - -
40 McCluccage + + - - - - + + - +
41 McCluccage + - - - - - + + - -
69 Rua Micheletti + - - - -
70 Kerkuta + - - - - + +
71 Lane + + - - - + +
74 Arsenovic + + - - - + +
73 Maggiani - - + - + +
76 Val-Bernal + + - - - - - + +
77 Val-Bernal + - - - -
78 Mandato + +
SMA smooth muscle actin, EMA epithelial membrane antigen, ER/PR estrogen/progesterone receptor
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the vulvo-vaginal/perineal/inguinal regions, which occurs
mainly in women in third to fifth decades [26–28]. It is
easily distinguishable from CA because it is generally a
large deep-seated lesion, poorly circumscribed with infil-
trative edges: AA tends to display an infiltrative growth
with entrapment of mucosal glands, fat, muscle and
nerves. Microscopically, aggressive angiomyxoma is hypo-
cellular, compared with CA, and it is composed of short
spindle tumour cells with minimal atypia in myxoid
stroma. Small clusters of smooth muscle cells surrounding
or “spinning off from” blood vessels are a characteristic
feature of AA [3]. There is a variable positivity for desmin,
smooth muscle actin and CD34 [7, 27, 28].
Angiomyofibroblastoma is a benign tumour most com-
monly occurring in the vulva of peri- and post-menopausal
women [29, 30]. Like CA, AMF is well circumscribed,
even well demarcated, usually with a thin fibrous capsule
but, unlike to CA, it is characterized by alternating hypo-
cellular and hypercellular areas, together with multinucle-
ate cells and epithelioid or plasmacytoid cells arranged in
cords and nets around vessels. In fact, the characteristic
feature of angiomyofibroblastoma is the perivascular ac-
centuation of tumor cells [29, 30]. In aid to differential
diagnosis, the immunochemistry is very useful because the
tumour cells of AMF express desmin and rarely CD34 and
smooth muscle actin [7, 29, 30].
Finally, vulvar smooth muscle tumours can be easily
distinguished from CA because the latter lacks typical
features of smooth muscle differentiation and it is usu-
ally desmin negative. The smooth muscle neoplasm are
classically composed of cells with blunt-ended nuclei
and eosinophilic cytoplasm, although these histological
features could be absent when the tumour is localized in
the vulvovaginal region.
The immunohistochemical features of CA may be help-
ful in differential diagnosis with the other vulvovaginal
soft tissue tumours. An interesting immunohistochemical
finding is the Estrogen and/or Progesterone receptors
(ER/PR) expression by the CA. The occurrence of CA
during menopausal transition and post-menopausal period
and the description of a two cases associated with long-
term estrogen replacement therapy [11, 15] support the
hypothesis of an hormonal pathogenetic origin. However,
the direct role of these steroids in the CA pathogenesis
still remains unclear, since a subset of mesenchymal cells
of the distal female genital tract normally expresses these
receptors and, at the same time, the neoplastic cells in
other soft tissue disorders, arising from the vulva, may
also show immunoreactivity for ER and/or PR [31].
Immunohistochemistry may be also helpful in differ-
ential diagnosis between usual CA and CA with atypia
or sarcomatous transformation. p16 expression is com-
monly negative in usual CA whilst is multifocal or dif-
fuse in CA with atypia or sarcomatous transformation
[9]. The p16 and p53 represent tumour suppressor genes
involving in the regulation of molecular pathways that
may play a role in the tumour progression in sarcomas:
overexpression of p16 may participate in the molecular
mechanisms underlying the atypical or sarcomatous
transformation seen in some subset of CA [9].
Recently fluorescent in situ hybridization (FISH) [13]
has shown a genetic relationship between CA, mammary-
type myofibroblastoma and spindle cell lipoma. The same
monoallelic or biallelic loss of retinoblastoma (RB) 1
(13q14), suggested a spectrum of one entity with morpho-
logical variations dependent on anatomic location. This
argument doesn’t apply to solitary fibrous tumour as
pubblished by Fritchie et al. [26] that shows the absence
of monoallelic/biallelic RB1 loss by FISH, arguing against
the concept the solitary fibrous tumour is genetically re-
lated to the other three entities.
RB is an important tumor suppressor protein that
plays a crucial role in cell cycle progression [32]. RB
gene is located at 13q14. Disruptions to the RB protein
and to the pathway controlled by RB confer proliferative
advantage to tumor cells [33]. In 13q14 gene is located
Table 4 Immunohistochemical features of CA and vulvar tumours for differential diagnosis
Vimentin CD34 S-100 α-SMA Desmin Keratin EMA ER PR h-Caldesmon CD-10 ACTIN STAT-6
Agressive Angiomyxoma 3+ 1+ 1+ 3+ 3+ 3+ 1+
Angiomyfibroblastoma 3+ 1+ 3+ 3+ 3+ 3+ 3-/1+
Ffibroepithelial stromal polyp 3+ 3+ 1+ 1+ 1+
Solitary fibrous tumour 3+ 3+
Smooth muscle neoplasm 3+ 3+
Spindle cell lipoma 3+
Angiofibroma of soft tissue 1+ 1+ 1+ 2+
Superficial myofibroblastoma of the
lower female genital tract
3+ 1+ 3- 1+ 2+ 3- 3- 3+ 3+
Cellular Angiofibroma 3+ 2+ 3- 2- 2- 3- 3+ 3+ 2- 3-
(3+): most of cases positive; (2+): half of cases positive; (1+): few/some cases postive; (3-): typically negative; (2-): usually negative
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also a tumor suppressor called Forkhead box protein O1
(FOXO1) [34]. FOXO1 is a transcription factor associ-
ated with apoptosis, cell cycle regulation, DNA repair
and resistance to oxidative stress [34]. A loss of FOXO1
expression was recently associated with CA [35]. FOXO1
transcription factor induces an increased expression of
manganese superoxide dismutase (MnSOD) resulting in
an elimination of the reactive oxygen species (ROS) [36].
Hence, loss of FOXO1 expression is associated with a de-
creased expression of MnSOD and, as consequence, an in-
creased intracellular ROS generation causing mutations in
proto-oncogenes and tumor suppressor genes [37]. In
fact, increased intracellular ROS induces p38 mitogen-
activated protein (MAPK) pathway and may be linked
to the tumorigenesis [36–38].
ROS can cause tumor development through cellular
proliferation, tumor cell invasion, angiogenesis and can-
cer stem cell survival [37]. Also mammary and vaginal
myofibroblastomas can present a monoallelic deletion of
FOXO1 [31]. Hence, RB1 and FOXO1 loss of expression
could be implicated in the pathogenesis of CA [13, 39].
RB1 and FOXO1 FISH analysis could be used to support
CA diagnosis but the specificity is uncertain [13].
Also CA pathogenesis is still unclear, both sexual hor-
mones and ROS has been proposed. Although human
papillomavirus (HPV) E7 oncoprotein bind RB protein
causing a loss of function [40], to our knowledge no role
of infections in the pathogenesis of CA has been studied.
CA appears to behave in a benign fashion, since there
is no report of tumours that progressed with metastasis
and there is described only a recurrent case [12]. The
primary and the recurrent CA consisted of a well cir-
cumscribed solid white mass of 4 and 6.5 cm respect-
ively. The histology of both lesions didn’t consistently
differ: the recurrent lesion showed foci of increased
cellularity and decreased vascularity compared with the
original specimen although there were no histological
features to suggest malignancy and 33 months after the
excision of the recurrent CA, there were no evidences of
further local recurrence.
In the majority of the analysed cases, the surgical ap-
proach consists of a simple local excision or a “shelling
out” and these treatments seem to be adequate also in
case of atypia and/or sarcomatous transformation where
the literature suggests a radical excision with free mar-
gins [9, 12]. To date, we are not aware of any cases of
metastases of these tumours with atypia/sarcomatous
features, suggesting that morphological atypical or sar-
comatous aspects don’t necessarily confer an aggressive
biologic behaviour to CA. Moreover, only 5 cases (5/18,
27.8 %) of re-excision because involved surgical margins
has been reported but this method doesn’t represent an
elective procedure because the tumour is usually treated
with a local excision also when there are positive surgical
margins, as showed in the remaining 13 cases (13/18,
72.2 %) with positive surgical margins, although no
recurrences or metastasis have been reported. Therefore,
considering that also cases of CA with positive margins
don’t recur, no wide excision should be required. Given
the relative sensitivity of the most frequently affected
anatomic sites, there seems to be no justification for
attempting to obtain a larger surgical margins [3].
Conclusions
In summary, CA in women represents a distinct benign
neoplasm with a broad anatomic distribution even if it is
mainly localized in the vulvo-vaginal area. This lesion may
exhibit some variations in its phenotypic features, as well
as atypia and morphologic features of sarcomatous trans-
formation but these characteristics seem not to predispose
to a malignant fashion and recurrences. For these reasons,
a treatment of simple local excision or a “shelling out” of
the lesion appear to be adequate and effective to avoid
recurrences and injuries to surrounding tissues.
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